Journal Reviews

BJUI International journal cover image.

BCG after TURBT – does timing matter?

2 March 2022 | | Urologic Oncology | #BladderCancer, #blcsm, #uroonc, BCG-unresponsive, bacille Calmette-Guérin, bladder cancer, intravesical therapy, transurethral resection of bladder tumour

Intravesical bacille Calmette–Guerin (BCG) therapy continues to be widely used for patients with intermediate / high-risk non-muscle invasive bladder cancer (NMIBC). In this article, the researchers identified the lack of sufficient evidence with regards to timing of BCG after transurethral...